Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Presenting...β-Secretase
21 October 1999. According to a report in tomorrow's Science, researchers have uncovered a strong candidate for β-secretase, the mystery enzyme that cleaves APP and allows Aβ to be formed in subsequent cleavages. Martin Cintron, Robert Vassar, Brian Bennett and colleagues at Amgen, Inc., report that a novel transmembrane aspartic protease termed BACE (for β-site APP-cleaving enzyme) has all the known characteristics of β-secretase.

Citron and his colleagues used an expression cloning strategy to find genes that modulate APP. Their search turned up a gene coding for a protein with a number of features associated with type I transmembrane proteins, and with its active site in the lumen, which is where β-secretase cleaves APP. They report that overexpression of this protein led to an overproduction of β-secretase products, cleaved without fail at known β-secretase sites, from both wildtype and Swedish-mutation APP. A number of other experiments also supported BACE as being β-secretase. For example, cellular and intracellular expression patterns parallel what is known about β-secretase.

Is BACE the real thing, or another hopeful candidate that will disappoint? Quoted in a News article in the same issue, Sam Sisodia of the University of Chicago said that evidence for BACE "is incontrovertible. I was floored by the data." The obvious next steps are to find inhibitors of BACE that could, in the most optimistic view, prevent or reverse Aβ deposition in Alzheimer's. At the very least, they will help answer the question of whether Aβ is the agent of neuronal destruction.-Hakon Heimer.

Comment:-Posted 12 November 1999
Two groups announced today in Science that BACE maps to chromosome 11. In a technical comment, Aleister Saunders and colleagues at Massachusetts General Hospital also report that a BACE homolog, which they call BACE2, resides on the obligatory Down's syndrome region of chromosome 21. In response, Fan et al. report that experiments using BACE antisense oligonucleotides in HEK 293 cells suggest that BACE2 is unlikely to be the principal β-secretase, at least not in these cells.

Reference:Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, Teplow DB, Ross S, Amarante P, Loeloff R, Luo Y, Fisher S, Fuller J, Edenson S, Lile J, Jarosinski MA, Biere AL, Curran E, Burgess T, Louis JC, Collins F, Treanor J, Rogers G, Citron M. b-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 1999 Oct 22;286:735-41. Abstract

Saunders AJ, Kim T-W, Tanzi RE. BACE maps to chromosome 11 and a BACE homolog, BACE2, reside in the obligate Down’s syndrome region of chromosome 21. Science 1999 Nov 12;(286):1255a.Full text (subscribers only).

Fan W, Bennett BD, Babu-Kahn S, Yi L, Louis J-C, McCaleb M, Citron M, Vassar R, Richards WG. Reply to above. Science 1999 Nov 12;(286):1255a.

 
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad